Stockreport

The Bull Case For Axsome Therapeutics (AXSM) Could Change Following Strong Auvelity Sales And Alzheimer's Label Hopes [Yahoo! Finance]

Axsome Therapeutics, Inc.  (AXSM) 
Last axsome therapeutics, inc. earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: axsome.com
PDF and roughly US$638,500,000 for full-year 2025, with its lead therapy Auvelity outperforming earlier sales estimates. At the same time, growing attention on Auvelity's [Read more]